MedPath

Study for optimizing the moment of Adaptive radiotherapy during curative radiotherapy or radiochemotherapy in Head and Neck cancer

Completed
Conditions
Head and Neck carcinoma
throat cancer
10027655
Registration Number
NL-OMON35249
Lead Sponsor
ederlands Kanker Instituut
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

- Signed written Informed Consent
- Squamouscell carcinoma in oral cavity, oropharynx, nasopharynx, larynx or hypopharynx
- adaptive radiotherapy or radiochemotherapy as primairy treatment

Exclusion Criteria

- < 18 years old
- pregnancy

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath